DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
DENTSPLY SIRONA Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $8.60, DENTSPLY SIRONA Inc. trades at 0.5x sales and 1.3x book value, with an EV/EBITDA of 11.2. Over the last twelve months it generated about $3.6B of revenue and a net loss of $121M. It runs a gross margin of 50.5%, an operating margin of 11.7% and a net margin of -3.4%. It shows return on equity of -9.0%, return on invested capital of 10.0% and a free cash flow yield of 6.0%. On the balance sheet: a debt-to-equity ratio of 1.69 and a current ratio of 1.63. Over the past 52 weeks the share price ranged from $8.14 to $14.76, with a beta of 0.86.
DENTSPLY SIRONA Inc. pays a dividend yielding 1.86%. Its Maz Dividend Score is 1.63 out of 5, ranked against the other dividend payers in its sector (Safety 1.10, Growth 3.10, Yield 4.50, Consistency 2.46).
32 Wall Street analyst ratings cover the stock: 12 Buy, 19 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, DENTSPLY SIRONA Inc. (XRAY) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 113.0% / 30% · (Cash+Inv) / Mkt Cap (36m) 10.0% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 113.0% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 10.0% / 33% · Receivables / Mkt Cap (36m) 31.1% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 113.0% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 10.0% / 33.33% · Receivables / Mkt Cap (24m) 31.1% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 42.9% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 4.51% / 33.33% · Receivables / Avg Assets (4Q) 12.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 42.4% / 33.33% · (Cash+ST Inv) / Total Assets 3.76% / 33.33% · (Cash+Recv) / Total Assets 15.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, DENTSPLY SIRONA Inc. (XRAY) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. DENTSPLY SIRONA Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
DENTSPLY SIRONA Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.